Ledger.Open graph →
SEC Form D · filed June 1, 2018

Quellis Biosciences, Inc

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Fred Callori · Philadelphia, PADirectorPeter Harwin · Philadelphia, PAExec · DirectorDebora M. Covell · Wyomissing, KYExec · DirectorChris Garabedian · Delanson, NYDirectorDavid H. Treitel · Boca Raton, FLExec · DirectorTomas Kiselak · Philadelphia, PAExec · DirectorFred Callori · Philadelphia, PADirectorJames C. Waldinger · New York, NYExec · DirectorStephen M. Wagman · Boca Raton, FLExec · DirectorChris Garabedian · Delanson, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗